Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Bitcoin ETFs: New Gold Rush for Financial Institutions

theguru Views  

Major institutional investors disclose 13F filings, including Park Avenue Securities
Positive outlook amid Bitcoin halving

Global financial companies were confirmed to have made large purchases of Bitcoin spot ETFs in the first quarter of this year. Analysis suggests growing confidence in Bitcoin’s investment value.

According to the 13F (Form 13) submitted to the U.S. Securities and Exchange Commission (SEC) on the 15th, major institutional investors increased their purchases of Bitcoin spot ETFs in the first quarter of this year. The 13F is a report form that institutional investors with a stock asset value of over $100 million submit quarterly.

Among the largest institutional investors, Park Avenue Securities LLC, boasting an AUM (assets under management) of $9.9 billion, made the list. Park Avenue Securities purchased Grayscale’s GBTC.

Inscription Capital LLC, which manages about $1.3 billion in assets, also bought Bitcoin spot ETFs. American National Bank and Wedmont Private Capital also purchased Bitcoin spot ETFs, with scales ranging from thousands to hundreds of thousands of dollars.

Overall, it appears that not only major institutional investors but also family offices, banks, and investment funds are still increasing their purchases of Bitcoin spot ETFs. This buying trend is seen as a reflection of growing confidence in Bitcoin’s investment value.

The upcoming Bitcoin halving, expected to occur between the 18th and 21st, is also projected to have a positive impact. When the halving begins, the Bitcoin block rewards decrease from the existing 6.25 bitcoins to 3.125 bitcoins. Since the supply of Bitcoin decreases, it is typically predicted that a price increase will occur due to the reduced supply.

The fact that Hong Kong’s financial authorities are preparing to approve Bitcoin and Ethereum spot ETFs is also a positive factor. Since the U.S. financial authorities approved the Bitcoin spot ETF last January, 11 ETFs in the U.S. have attracted about $59 billion in funds.

theguru
content@viewusglobal.com

Comments0

300

Comments0

[BUSINESS] Latest Stories

  • Honda's NSX Returns: A 1,000-Horsepower Electric Rival to Lexus LFR
  • Honda’s S7 Electric SUV: A Major Player in the Race for EV Dominance
  • Lamborghini's First EV: A 2,000-Horsepower Beast Built for Speed and Emotion
  • Ford Revives Classic Design with the 2025 Bronco Heritage Edition
  • ID.EVERY1: Volkswagen's $21K Electric Vehicle Aims to Make Green Driving Accessible
  • Toyota’s bZ3X SUV Surges with 10,000 Pre-Orders: A New Era in EVs

You May Also Like

  • 1
    How Vitamin D Could Help Lower Colon Cancer Risk

    LIFESTYLE 

  • 2
    Yes, IVF Can Cause Weight Gain — Here's Why You Shouldn't Panic

    LIFESTYLE 

  • 3
    Red Jewels for Your Health: 7 Amazing Benefits of Pomegranates

    LIFESTYLE 

  • 4
    Hidden Danger: 5 'Healthy Foods' That Can Worsen Gout

    LIFESTYLE 

  • 5
    Spring’s Secret Weapon for Dry Coughs: Meet Liriope Tea

    LIFESTYLE 

Popular Now

  • 1
    FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder

    LIFESTYLE&nbsp

  • 2
    Experts Warn: Toss Your Expired Sunscreen Before It Hurts Your Skin

    LIFESTYLE&nbsp

  • 3
    New Drug Helps Patients with Myasthenia Gravis Breathe and Speak Easier

    LIFESTYLE&nbsp

  • 4
    Bristol-Myers’ Schizophrenia Drug Falls Short in Key Trial

    LIFESTYLE&nbsp

  • 5
    Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDA

    LIFESTYLE&nbsp

Must-Reads

  • 1
    How Vitamin D Could Help Lower Colon Cancer Risk

    LIFESTYLE 

  • 2
    Yes, IVF Can Cause Weight Gain — Here's Why You Shouldn't Panic

    LIFESTYLE 

  • 3
    Red Jewels for Your Health: 7 Amazing Benefits of Pomegranates

    LIFESTYLE 

  • 4
    Hidden Danger: 5 'Healthy Foods' That Can Worsen Gout

    LIFESTYLE 

  • 5
    Spring’s Secret Weapon for Dry Coughs: Meet Liriope Tea

    LIFESTYLE 

Popular Now

  • 1
    FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder

    LIFESTYLE 

  • 2
    Experts Warn: Toss Your Expired Sunscreen Before It Hurts Your Skin

    LIFESTYLE 

  • 3
    New Drug Helps Patients with Myasthenia Gravis Breathe and Speak Easier

    LIFESTYLE 

  • 4
    Bristol-Myers’ Schizophrenia Drug Falls Short in Key Trial

    LIFESTYLE 

  • 5
    Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDA

    LIFESTYLE